Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 129

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling

Lim, Junxian, Iyer, Abishek, Suen, Jacky Y., Seow, Vernon, Reid, Robert C., Brown, Lindsay, Fairlie, David P. · 2013 · The FASEB Journal

Abstract

Mammalian survival depends on metabolizing nutrients, storing energy, and combating infection. Complement activation in blood triggers energy‐depleting immune responses to fight infections. Here we identify surprising energy‐conserving roles for complement proteins C5a and C3a and their receptors, C5aR and C3aR, roles that are contraindicated in complement biology. Rats fed a high‐carbohydrate high‐fat diet developed obesity, visceral adiposity, adipose inflammation, glucose/insulin intolerance, and cardiovascular dysfunction that correlated with increased plasma C3a, adipose C5aR, and C3aR. These in vivo changes were dramatically attenuated by receptor‐selective antagonists of either C5aR (5 mg/kg/d p.o.) or C3aR (30 mg/kg/d p.o.), which both reduced proinflammatory adipokines and altered expression of inflammatory genes in adipose tissue. In vitro C5a and C3a (100 nM) exhibited novel insulin‐like effects on 3T3‐L1 adipocytes, promoting energy conservation by increasing glucose and fatty acid uptake while inhibiting cAMP signaling and lipolysis, and induced PGE 2 release from macrophages, effects all blocked by each respective antagonist (10 μM). These studies reveal important new links between complement signaling and metabolism, highlight new complement functions on adipocytes and in adipose tissue, demonstrate how aberrant immune responses may exacerbate obesity and metabolic dysfunction, and show that targeting C3aR or C5aR with antagonists is a new strategy for treating metabolic dysfunction.—Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., Fairlie, D. P. C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 27, 822–831 (2013). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.12-220582

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 28

  1. 10.1038/nrendo.2009.264 · DOI · Paper page
  2. 10.1038/nature05485 · DOI · Paper page
  3. 10.1210/jcem.87.7.8638 · doi:10.1210/jcem.87.7.8638 · Paper page
  4. 10.2337/db06-1491 · DOI · Paper page
  5. 10.1038/4641287a · DOI
  6. 10.1038/sj.bjp.0707332 · DOI · Paper page
  7. 10.1016/S0021-9258(18)42338-1 · DOI · Paper page
  8. 10.1152/ajpendo.00664.2006 · DOI
  9. 10.1007/s00125-005-0021-6 · DOI
  10. 10.3945/ajcn.2009.28101 · DOI
  11. 10.2337/diacare.23.6.779 · DOI
  12. 10.1074/jbc.M609734200 · DOI
  13. 10.1097/FJC.0b013e3181feb90a · DOI · Paper page
  14. 10.1021/jm9806594 · DOI · Paper page
  15. 10.1021/jm9800651 · DOI
  16. 10.4049/jimmunol.166.10.6341 · DOI · Paper page
  17. 10.1111/j.1476-5381.2010.00637.x · DOI
  18. 10.1371/journal.pone.0013809 · DOI
  19. 10.1016/j.ab.2010.05.012 · doi:10.1016/j.ab.2010.05.012
  20. Scully C. C., 2010, Selective hexapeptide agonists and antagonists for human complement C3a receptor, J. Med. Chem., 53, 4938, 10.1021/jm1003705 · doi:10.1021/jm1003705
  21. 10.1074/jbc.M609178200 · DOI
  22. 10.1177/1087057109341407 · DOI
  23. 10.1172/JCI200319451 · DOI · Paper page
  24. 10.1038/nm.1904 · DOI · Paper page
  25. 10.1073/pnas.78.2.732 · DOI
  26. 10.1038/ng.325 · DOI · Paper page
  27. 10.2337/db09-0323 · DOI · Paper page
  28. 10.1038/sj.bjp.0705819 · DOI

Cited by

See all 129

Metadata

Authors
Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., & Fairlie, D. P.
Venue
The FASEB Journal
Publisher
Wiley
Published
2012-11
Volume
27
Issue
2
Pages
822-831
ISSN
  • 0892-6638
  • 1530-6860
Cited by
129
References
15
Language
en
Funders
Centre of Excellence for Environmental Decisions, Australian Research Council (DP1093245)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. https://app.cochat.ai/papers/10.1096/fj.12-220582
The paper
Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., & Fairlie, D. P. (2013). C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. The FASEB Journal. https://doi.org/10.1096/fj.12-220582

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.